Status:

TERMINATED

Safety and Efficacy of Chlorthalidone in Type 1 Diabetes

Lead Sponsor:

University of Rochester

Collaborating Sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Type 1 Diabetes Mellitus

Hypercalciuria

Eligibility:

All Genders

12-21 years

Phase:

PHASE2

Brief Summary

This open-label study will determine if chlorthalidone is safe and effective for the use of reducing urinary calcium excretion over 4 weeks in subjects with type 1 diabetes

Detailed Description

Type 1 diabetes (T1D) is associated with increased urinary calcium loss, which may contribute to the low bone mineral density and increased fracture risk observed in patients with this condition. Chlo...

Eligibility Criteria

Inclusion

  • Diagnosis of T1D
  • Age 12-21 years
  • Tanner Stage 2 or greater pubertal development
  • Urine calcium excretion ≥ 4 mg/kg/day
  • Able to swallow pills

Exclusion

  • BMI \> 99th percentile for age (\<18 years) or BMI \>35 kg/m2 (≥ 18 years)
  • Coexistent conditions that may affect calcium metabolism including:
  • celiac disease
  • Graves' Disease
  • Addison's disease
  • hypo- or hyperparathyroidism
  • History of diabetes related complications including:
  • neuropathy
  • retinopathy
  • nephropathy
  • gastroparesis
  • History of oral or inhaled corticosteroid use for ≥ 5 consecutive days within the past month
  • History of any diuretic use within the past month
  • Laboratory abnormalities on screening bloodwork including:
  • estimated glomerular filtration rate \<90 mL/min per 1.73 m2 of body surface area
  • serum calcium \>10.5 mg/dL
  • serum potassium \<3.5 mmol/L
  • Systolic or diastolic blood pressure \<5th percentile for age and sex50 for age \<18 years or systolic \<90 mmHg or diastolic blood pressure \<60 mmHG for age ≥18 years

Key Trial Info

Start Date :

June 28 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2020

Estimated Enrollment :

1 Patients enrolled

Trial Details

Trial ID

NCT03325114

Start Date

June 28 2019

End Date

June 1 2020

Last Update

January 5 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Rochester

Rochester, New York, United States, 14642

Safety and Efficacy of Chlorthalidone in Type 1 Diabetes | DecenTrialz